# Testing Miglustat Administration in Subjects With Spastic Paraplegia 11

> **NCT04768166** · PHASE2 · COMPLETED · sponsor: **IRCCS Fondazione Stella Maris** · enrollment: 10 (actual)

## Conditions studied

- Hereditary Spastic Paraparesis

## Interventions

- **DRUG:** Miglustat 100 MG

## Key facts

- **NCT ID:** NCT04768166
- **Lead sponsor:** IRCCS Fondazione Stella Maris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-15
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-09-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768166, "Testing Miglustat Administration in Subjects With Spastic Paraplegia 11". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04768166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*